344 related articles for article (PubMed ID: 26612218)
1. Emerging Entities in Renal Neoplasia.
Mehra R; Smith SC; Divatia M; Amin MB
Surg Pathol Clin; 2015 Dec; 8(4):623-56. PubMed ID: 26612218
[TBL] [Abstract][Full Text] [Related]
2. The evolving classification of renal cell neoplasia.
Delahunt B; Srigley JR
Semin Diagn Pathol; 2015 Mar; 32(2):90-102. PubMed ID: 25753529
[TBL] [Abstract][Full Text] [Related]
3. Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification.
Udager AM; Mehra R
Arch Pathol Lab Med; 2016 Oct; 140(10):1026-37. PubMed ID: 27684973
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic approach to eosinophilic renal neoplasms.
Kryvenko ON; Jorda M; Argani P; Epstein JI
Arch Pathol Lab Med; 2014 Nov; 138(11):1531-41. PubMed ID: 25357116
[TBL] [Abstract][Full Text] [Related]
5. [International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia 2012].
Hes O
Cesk Patol; 2014; 50(4):137-41. PubMed ID: 25418900
[TBL] [Abstract][Full Text] [Related]
6. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.
Srigley JR; Delahunt B; Eble JN; Egevad L; Epstein JI; Grignon D; Hes O; Moch H; Montironi R; Tickoo SK; Zhou M; Argani P;
Am J Surg Pathol; 2013 Oct; 37(10):1469-89. PubMed ID: 24025519
[TBL] [Abstract][Full Text] [Related]
7. Advances in renal neoplasia: recommendations from the 2012 International Society of Urological Pathology Consensus Conference.
Delahunt B; Srigley JR; Montironi R; Egevad L
Urology; 2014 May; 83(5):969-74. PubMed ID: 24661331
[TBL] [Abstract][Full Text] [Related]
8. [Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)].
Kristiansen G; Delahunt B; Srigley JR; Lüders C; Lunkenheimer JM; Gevensleben H; Thiesler T; Montironi R; Egevad L
Pathologe; 2015 May; 36(3):310-6. PubMed ID: 25398389
[TBL] [Abstract][Full Text] [Related]
9. Knowledge of hereditary renal cancer syndromes: a pending issue for oncologists.
García-Donas J; Hernando S; Romero N; Jara C
Anticancer Drugs; 2011 Jan; 22 Suppl 1():S15-20. PubMed ID: 21173603
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas.
Seo AN; Yoon G; Ro JY
Adv Anat Pathol; 2017 Mar; 24(2):65-77. PubMed ID: 28181950
[TBL] [Abstract][Full Text] [Related]
11. Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases.
Ulamec M; Skenderi F; Zhou M; Krušlin B; Martínek P; Grossmann P; Peckova K; Alvarado-Cabrero I; Kalusova K; Kokoskova B; Rotterova P; Hora M; Daum O; Dubova M; Bauleth K; Slouka D; Sperga M; Davidson W; Rychly B; Perez Montiel D; Michal M; Hes O
Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):521-30. PubMed ID: 26447894
[TBL] [Abstract][Full Text] [Related]
12. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
Moch H; Cubilla AL; Humphrey PA; Reuter VE; Ulbright TM
Eur Urol; 2016 Jul; 70(1):93-105. PubMed ID: 26935559
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma and mimics: pathologic primer for radiologists.
Bai X; Wu CL
AJR Am J Roentgenol; 2012 Jun; 198(6):1289-93. PubMed ID: 22623540
[TBL] [Abstract][Full Text] [Related]
14. Adult Renal Cell Carcinoma: A Review of Established Entities from Morphology to Molecular Genetics.
Hirsch MS; Signoretti S; Dal Cin P
Surg Pathol Clin; 2015 Dec; 8(4):587-621. PubMed ID: 26612217
[TBL] [Abstract][Full Text] [Related]
15. The syndrome of hereditary leiomyomatosis and renal cell cancer (HLRCC): The clinical features of an individual with a fumarate hydratase gene mutation.
Varol A; Stapleton K; Roscioli T
Australas J Dermatol; 2006 Nov; 47(4):274-6. PubMed ID: 17034471
[TBL] [Abstract][Full Text] [Related]
16. Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors.
Hamza A; Sirohi D; Smith SC; Amin MB
Adv Anat Pathol; 2021 Nov; 28(6):396-407. PubMed ID: 34561376
[TBL] [Abstract][Full Text] [Related]
17. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
18. New entities, new technologies, new findings: A review of the cytologic features of recently established subtypes of renal cell carcinoma.
Robila V; Kraft AO; Smith SC
Cancer Cytopathol; 2019 Feb; 127(2):79-97. PubMed ID: 30690877
[TBL] [Abstract][Full Text] [Related]
19. Recent advances of immunohistochemistry for diagnosis of renal tumors.
Kuroda N; Tanaka A; Ohe C; Nagashima Y
Pathol Int; 2013 Aug; 63(8):381-90. PubMed ID: 23957913
[TBL] [Abstract][Full Text] [Related]
20. [Characterization of different renal cell carcinoma entities].
Rupp NJ; Moch H
Urologe A; 2020 Feb; 59(2):135-141. PubMed ID: 31974661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]